Coronavirus

Markets

Moderna, Pfizer, J&J talk omicron response

As COVID-19's new omicron variant has begun to emerge overseas, vaccine makers Moderna, Pfizer and Johnson & Johnson have outlined their respective strategies to tackle the new strain.